Overview

Clostridium Histolyticum Collagenase Injection for Urethral Disease

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of clostridium histolyticum collagenase (XIAFLEX®) in treating urethral strictures.
Phase:
Phase 2
Details
Lead Sponsor:
University of South Florida
Treatments:
Lidocaine